Alexion Pharmaceuticals Market Cap:
20.05B for May 21, 2013Alexion Pharmaceuticals Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 21, 2013 | 20.05B |
| May 20, 2013 | 19.52B |
| May 17, 2013 | 20.08B |
| May 16, 2013 | 19.87B |
| May 15, 2013 | 20.53B |
| May 14, 2013 | 21.05B |
| May 13, 2013 | 20.46B |
| May 10, 2013 | 20.32B |
| May 9, 2013 | 19.16B |
| May 8, 2013 | 18.85B |
| May 7, 2013 | 18.80B |
| May 6, 2013 | 18.94B |
| May 3, 2013 | 19.16B |
| May 2, 2013 | 18.77B |
| May 1, 2013 | 18.86B |
| April 30, 2013 | 19.12B |
| April 29, 2013 | 19.25B |
| April 26, 2013 | 19.39B |
| April 25, 2013 | 19.28B |
| April 24, 2013 | 17.41B |
| April 23, 2013 | 17.89B |
| April 22, 2013 | 17.64B |
| April 19, 2013 | 18.06B |
| April 18, 2013 | 17.95B |
| April 17, 2013 | 18.48B |
| April 16, 2013 | 18.76B |
| April 15, 2013 | 18.77B |
| April 12, 2013 | 19.53B |
| April 11, 2013 | 19.59B |
| April 10, 2013 | 19.52B |
| April 9, 2013 | 19.18B |
| April 8, 2013 | 19.15B |
| April 5, 2013 | 19.35B |
| April 4, 2013 | 19.29B |
| April 3, 2013 | 18.97B |
| April 2, 2013 | 19.32B |
| April 1, 2013 | 18.65B |
| March 28, 2013 | 17.99B |
| March 27, 2013 | 18.33B |
| March 26, 2013 | 17.84B |
| March 25, 2013 | 18.03B |
| March 22, 2013 | 18.25B |
| March 21, 2013 | 18.03B |
| March 20, 2013 | 18.33B |
| March 19, 2013 | 18.10B |
| March 18, 2013 | 18.28B |
| March 15, 2013 | 18.28B |
| March 14, 2013 | 17.93B |
| March 13, 2013 | 17.86B |
| March 12, 2013 | 17.91B |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
ALXN Market Cap Benchmarks
| Companies | |
|---|---|
| Vertex Pharmaceuticals | 17.13B |
| Regeneron Pharmaceuticals | 25.83B |
| Athersys | 104.96M |
ALXN Market Cap Rankings
| Overall |
96th percentile 315 of 8002 |
| Sector |
95th percentile 30 of 684 in Healthcare |
| Industry |
97th percentile 7 of 248 in Biotechnology |
ALXN Market Cap Range, Past 5 Years
| Minimum | 2.416B | Nov 21 2008 |
| Maximum | 22.96B | Oct 5 2012 |
| Average | 9.087B |
